Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-03-18FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for carbamazepine, a generic anticonvulsant. This action updates the approval statu…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Health Promotion and Fitness for Younger and Older Adults With SMI [NA]
A completed clinical trial update evaluating health promotion and fitness interventions for younger and older adults with serious mental ill…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]
This Phase 3 multicenter trial evaluated the long-term safety and efficacy of aripiprazole in combination with a mood stabilizer for Bipolar…
-
FDA approval · 2014-03-10FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression [Phase 3]
Phase 3 trial evaluating adjunctive lisdexamfetamine for bipolar depression was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: The Young Adult and Pediatric Bipolar Study [Phase 4]
Phase 4 clinical trial update for Bipolar I Disorder in young adults and pediatric patients; the study has completed.
-
FDA approval · 2014-02-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for carbamazepine, a generic anticonvulsant.
-
FDA approval · 2014-02-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited, indicating updated authorization for the…
-
FDA approval · 2014-02-19FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for divalproex sodium from Unichem Pharmaceuticals (USA), Inc., indicating an approved change or add…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]
A Phase 3 multicenter, placebo-controlled extension study evaluated the safety and efficacy of aripiprazole in bipolar I disorder patients e…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]
A Phase 3 multicenter study evaluated extended administration of aripiprazole in combination with a mood stabilizer for Bipolar I Disorder p…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]
Phase 3 multicenter, randomized, double-blind, placebo-controlled trial evaluating aripiprazole for acute manic or mixed episodes in bipolar…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
A Janssen-sponsored clinical trial evaluating antipsychotic treatment in community behavioral health organizations for schizophrenia and bip…
-
FDA approval · 2014-02-11FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for divalproex sodium from Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: General Practice Research Database Seroquel XR Safety Study
A completed safety study evaluating quetiapine extended-release (Seroquel XR) in patients with schizophrenia, major depressive disorder, and…
-
FDA approval · 2014-02-05FDA Approved: DIVALPROEX SODIUM — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for divalproex sodium submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS research · 2014-01-31Clinical Trial Update: Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
This open-label pilot study assessed the pharmacokinetics of aripiprazole in adults with Bipolar I Disorder or schizophrenia; the study is c…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: The Effects of Cognitive Remediation on Cognitive Function in Remitted Bipolar Disorder - a Proof of Concept Study [NA]
This document reports on a completed proof-of-concept clinical trial examining whether cognitive remediation improves cognitive function in …
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Combination Therapy for the Treatment of Bipolar Disorders [Phase 3]
A Phase 3 trial evaluating a combination therapy for bipolar disorder was terminated, with results posted in January 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: EMR Data to Assess Monitoring of Patients Treated With Quetiapine
AstraZeneca conducted an EMR-based analysis to assess how patients treated with quetiapine are monitored in real-world clinical practice; th…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Functional Correlates of Bipolar Disorders and Effects of the Psychoeducation. an fMRI Study [NA]
Completed clinical study examining functional brain correlates of bipolar disorders and the effects of psychoeducation using functional MRI.
-
CLINICAL_TRIALS research · 2014-01-28Clinical Trial Update: Physician Survey on Monitoring of Patients Treated With Quetiapine
A completed physician survey update concerning monitoring practices for patients treated with quetiapine (Seroquel).
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Treatment and Outcome of Early Onset Bipolar Disorder [Phase 4]
Phase 4 clinical trial update describing treatment approaches and outcomes in early onset bipolar disorder.
-
CLINICAL_TRIALS withdrawal · 2014-01-22Clinical Trial Update: Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania [Phase 4]
A Phase 4 study assessing adjunctive lithium for psychotic mania in Bipolar I Disorder has been withdrawn.
-
CLINICAL_TRIALS research · 2014-01-17Clinical Trial Update: Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder
Clinical trial update on prospective metabolic monitoring of youth and adults with bipolar disorder; the study has completed.